DiaMedica Therapeutics Inc. (DMAC) › Total AssetsDiaMedica Therapeutics Inc. (DMAC) — Total AssetsAnnual figures by fiscal year, from SEC filings.2017: $1.80M2018: $18.34M2019: $9.05M2020: $28.09M2021: $45.55M2022: $34.40M2023: $54.16M2024: $46.34M2025: $61.37M$61.37M2017Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$61.37M+32.4%2024$46.34M-14.4%2023$54.16M+57.5%2022$34.40M-24.5%2021$45.55M+62.1%2020$28.09M+210.3%2019$9.05M-50.6%2018$18.34M+917.7%2017$1.80M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share